Dual Immune Checkpoint Inhibition in Patients with Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial
Kartik Sehgal*, Theodora Pappa, Kee Young Shin, Julia Schiantarelli, Mofei Liu, Cora Ricker, Naomi R. Besson, Stephanie M. Jones, Emma L. Welsh, Kathleen L. Pfaff, Justine A. Barletta, Jihye Park, Brendan Reardon, Gerard M. Doherty, Erik K. Alexander, Scott J. Rodig, David A. Barbie, Anne O'Neill, Eliezer Van Allen, Robert I. HaddadJochen H. Lorch
Dive into the research topics of 'Dual Immune Checkpoint Inhibition in Patients with Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial'. Together they form a unique fingerprint.